Evidence map›Paper›PMID 40727887›Full record

ArticleTherapeutic advances in medical oncology2025

Pancreatic neuroendocrine tumors and

Rachel P Riechelmann, Giovana T Torrezan, Emily Bergsland, Nitya Raj, Jonathan Strosberg, Farhana Moon, Tiago C Felismino, Stian Knappskog, Elena Trevizani, Sara Cingarlini and 1 more

Abstract read
In one paragraph

Article in Therapeutic advances in medical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel P RiechelmannDepartment of Clinical Oncology and Neuroendocrine Tumors Reference Center, AC Camargo Cancer Center, Rua Antônio Prudente 211, São Paulo 01509-010, Brazil.ORCID https://orcid.org/0000-0002-0107-9617
Giovana T TorrezanClinical and Functional Genomics Group, AC Camargo Cancer Center, São Paulo, Brazil.
Emily BergslandDepartment of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
Nitya RajGastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jonathan StrosbergMoffitt Cancer Center, Tampa, FL, USA.
Farhana MoonHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
Tiago C FelisminoDepartment of Clinical Oncology and Neuroendocrine Tumors Reference Center, AC Camargo Cancer Center, São Paulo, Brazil.
Stian KnappskogK.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
Elena TrevizaniSection of Oncology, Department of Engineering for Innovation Medicine, University and Hospital Trust of Verona, Verona, Italy.
Sara CingarliniSection of Oncology, Department of Engineering for Innovation Medicine, University and Hospital Trust of Verona, Verona, Italy.
Halfdan SorbyeDepartment of Oncology, Haukeland University Hospital, Bergen, Norway.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Background: Germline pathogenic variants (GPV) in Objectives: We aimed to characterize PanNET patients with GPV and/or somatic pathogenic variants (SPV) in Design: Retrospective multicenter cohort. Methods: Patients with PanNET harboring Results: In total, 23 patients with Conclusion:

Indexed as

germlinemutationMUTYHneuroendocrine tumorspancreatic

Identifiers

PMID40727887
PMCPMC12301599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.